Symptom Resolution in Pediatric Patients With Lyme Disease

Mattia E Chason; Maureen Monaghan; Jichuan Wang; Yao Cheng; Roberta L DeBiasi

doi:10.1093/jpids/piy067

Symptom Resolution in Pediatric Patients With Lyme Disease

J Pediatric Infect Dis Soc. 2019 May 11;8(2):170-173. doi: 10.1093/jpids/piy067.

Authors

Mattia E Chason^{1

2}, Maureen Monaghan^{3

2}, Jichuan Wang⁴, Yao Cheng⁴, Roberta L DeBiasi^{5

2

6}

Affiliations

¹ Department of Pediatrics, Children's National Health System, Washington, DC.
² Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC.
³ Department of Psychology, Children's National Health System, Washington, DC.
⁴ Department of Biostatistics, Children's National Health System, Washington, DC.
⁵ Department of Pediatric Infectious Diseases, Children's National Health System, Washington, DC.
⁶ Department of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.

PMID: 30060012
DOI: 10.1093/jpids/piy067

Abstract

We performed a retrospective study to determine the time frame for symptom resolution in 78 pediatric patients hospitalized with laboratory-confirmed early-disseminated or late-stage Lyme disease. The vast majority of the patients improved promptly after receiving appropriate antibiotics. Patients with a longer duration of arthritis before the institution of therapy experienced a longer time to recovery.

Keywords: Lyme arthritis; Lyme disease; Lyme meningitis; pediatric.

© The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use*
Arthritis / drug therapy
Child
Child, Preschool
Hospitalization
Humans
Infant
Inpatients
Lyme Disease / drug therapy*
Retrospective Studies
Time Factors

Substances

Anti-Bacterial Agents